CRISAFULLI, Concetta
 Distribuzione geografica
Continente #
EU - Europa 6.051
NA - Nord America 5.465
AS - Asia 3.561
SA - Sud America 1.127
AF - Africa 90
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.304
Nazione #
US - Stati Uniti d'America 5.330
RU - Federazione Russa 2.991
SG - Singapore 1.726
BR - Brasile 975
CN - Cina 947
IE - Irlanda 719
SE - Svezia 665
HK - Hong Kong 370
GB - Regno Unito 342
IT - Italia 294
UA - Ucraina 288
DE - Germania 247
FR - Francia 158
VN - Vietnam 156
FI - Finlandia 128
IN - India 110
PL - Polonia 102
CA - Canada 81
AR - Argentina 49
BD - Bangladesh 38
EC - Ecuador 33
ZA - Sudafrica 31
TR - Turchia 28
MX - Messico 25
BE - Belgio 24
ID - Indonesia 22
CO - Colombia 20
UZ - Uzbekistan 19
MA - Marocco 18
NL - Olanda 18
IQ - Iraq 16
JP - Giappone 15
VE - Venezuela 15
PK - Pakistan 14
AT - Austria 12
ES - Italia 12
IL - Israele 11
LT - Lituania 10
TN - Tunisia 10
CL - Cile 9
KE - Kenya 9
UY - Uruguay 9
PE - Perù 8
JM - Giamaica 7
MY - Malesia 7
OM - Oman 7
SA - Arabia Saudita 7
AU - Australia 6
AZ - Azerbaigian 6
JO - Giordania 6
KZ - Kazakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
NP - Nepal 5
PH - Filippine 5
PT - Portogallo 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ET - Etiopia 4
KG - Kirghizistan 4
LB - Libano 4
RO - Romania 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
KR - Corea 3
RS - Serbia 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
BW - Botswana 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
Totale 16.292
Città #
Moscow 942
Singapore 783
Ashburn 725
Dublin 718
Dallas 640
Jacksonville 566
Chandler 549
Hong Kong 370
Nyköping 354
Beijing 332
San Jose 313
Lancaster 243
Dearborn 143
The Dalles 143
Princeton 136
Lauterbourg 121
Cambridge 118
Medford 110
Des Moines 109
Boardman 98
Warsaw 96
Los Angeles 94
Messina 94
São Paulo 83
Ann Arbor 72
New York 60
Buffalo 57
Tianjin 46
Ho Chi Minh City 45
Hyderabad 44
Redondo Beach 44
Hanoi 42
Wilmington 41
Woodbridge 38
Ottawa 34
Council Bluffs 32
Jinan 32
Houston 31
Munich 29
Santa Clara 28
Guangzhou 26
Belo Horizonte 25
Bremen 25
Rio de Janeiro 25
Brussels 24
Rome 23
Shenyang 23
Orem 21
Pune 21
Denver 20
Hebei 19
Frankfurt am Main 18
Tashkent 17
Brooklyn 16
Chicago 16
Johannesburg 16
Nanjing 16
Campinas 15
Porto Alegre 15
Salvador 15
Milan 14
Montreal 14
Ningbo 14
Quito 14
Seattle 14
Brasília 13
Haikou 13
San Francisco 13
Tokyo 13
Zhengzhou 13
Atlanta 12
Chennai 12
Curitiba 12
Hangzhou 12
Nanchang 12
Boston 11
Phoenix 11
San Mateo 11
Sorocaba 11
Taizhou 11
Bari 10
Guarulhos 10
Guayaquil 10
London 10
Mexico City 10
Baghdad 9
Cape Town 9
Nuremberg 9
Shanghai 9
Ankara 8
Columbus 8
Contagem 8
Falls Church 8
Hillsboro 8
Nairobi 8
Padova 8
Poplar 8
Toronto 8
Vienna 8
Catania 7
Totale 9.374
Nome #
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 255
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 250
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 238
CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study. 234
CCR5Δ32 Polymorphism Associated with a Slower Rate DiseaseProgression in a Cohort of RR-MS Sicilian Patients 206
CNVs inform the biological network of Autism spectrum disorder 202
A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment. 179
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 174
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 171
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 166
A genetic dissection of antipsychotic induced movement disorders 161
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 161
FMO3 allelic variants in a Mediterranean population frequency and linkage analysis. 158
Olprinone attenuates the development of ischemia/reperfusion injury of the gut 158
Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder 157
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 156
CASE-CONTROL ASSOCIATION STUDY FOR 10 GENES IN PATIENTS WITH SCHIZOPHRENIA: INFLUENCE OF 5HTR1A VARIATION rs10042486 ON SCHIZOPHRENIA AND RESPONSE TO ANTIPSYCHOTICS. 155
Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder 155
CASE-CONTROL ASSOCIATION STUDY OF GRIA1, GRIA2 AND GRIA4 POLYMORPHISMS IN BIPOLAR DISORDER. 149
Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls 148
CASE-CONTROL ASSOCIATION STUDY OF 14 VARIANTS OF CREB1, CREBBP AND CREM ON DIAGNOSIS AND TREATMENT OUTCOME IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER. 146
The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants 144
PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway. 141
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept 141
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON SEPTICK SHOCK IN MICE 141
GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice 140
Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1 140
Alzheimer's Disease and Neurotransmission Gene Variants: Focus on Their Effects on Psychiatric Comorbidities and Inflammatory Parameters 139
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses 136
ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders 135
Molecular Pathways within Autism Spectrum Disorder Endophenotypes 135
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. 133
Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study 133
Genetic variants associated with psychotic symptoms across psychiatric disorders 132
Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. 130
Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats 130
Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice 130
Genetic Insights from a Molecular Pathway Analysis on Two Independent Samples of Autistic Patients 130
Green Tea polyphenol extract attenuates zymosan-induced non-septic shock in mice 129
Melatonin modulates signal transduction pathways and apoptosis in experimental colitis 127
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 126
FKBP5 Gene Variants May Modulate Depressive Features in Bipolar Disorder. 126
The Role of Nanotechnologies in Brain Tumors 125
NOVEL PDCD10 PROMOTER VARIANTS IN PATIENTS WITH CEREBRAL CAVERNOUSMALFORMATIONS 125
Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1 123
Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma 122
Effects of verbascoside, biotechnologically purified by Syringa vulgaris plant cell cultures, in a rodent model of periodontitis 121
Protective effect of hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome. 119
Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation 119
Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury. 118
AB0132 THE IMPACT OF FIBROMYALGIA AND FIBROMYALGIA-RELATED SYMPTOMS ON TREATMENT ADHERENCE IN A COHORT OF PATIENTS WITH RHEUMATIC DISEASES: RESULTS OF A PILOT CROSS-SECTIONAL STUDY 117
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 117
Molecular analysis of CCM genes promoter regions 116
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy 114
Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein 113
Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice 111
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 111
Neuronal cell adhesion genes and antidepressant response in three independent samples 111
Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model. 109
Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. 109
The biological pathways of Alzheimer disease: a review 109
Body weight changes and bipolar disorder: a molecular pathway analysis 108
SOLUBLE GITR (GLUCOCORTICOID- INDUCED TNFR- RELATED GENE) FUSION PROTEIN INHIBITS ACUTE LUNG INFLAMMATION. 108
Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells 106
TNF-α blockage in a mouse model of SCI: Evidence for improved outcome 106
Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma 105
Alzheimer: A Complex Genetic Background 105
Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features 103
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study 103
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury 102
Glycogen synthase kinase-3 beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut 99
Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice 99
Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. 99
Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia 99
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord 98
Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. 98
Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, amelioratesintestinal damage in rat models of colitis and shock 98
Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats 97
TNF-alpha inhibition prevents early tight junction rearrangement and apoptosis of ileal enterocytes in experimental colitis. 97
Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. 96
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 96
Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma 94
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance 93
Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (Molecular Biology Reports, (2020), 47, 1, (191-200), 10.1007/s11033-019-05119-5) 93
Role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor α in the development of bleomycin-induced lung injury 93
Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. 93
Immunomodulatory effects of etanercept in an experimental model of spinal cord injury 91
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury 90
Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. 90
Estrogen Receptor-{alpha} as a Drug Target Candidate for Preventing Lung Inflammation. 90
COMT AND AGE AT ONSET IN MOOD DISORDERS: A REPLICATION AND EXTENSION STUDY. 90
Progress and prospects in pharmacogenetics of antidepressant drugs 90
Possible Modulatory Role of ARC Gene Variants in Mood Disorders 90
Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation 89
Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis 89
FAILURE TO REPLICATE INFLUENCE OF GRIK4 AND GNB3 POLYMORPHISMS ON TREATMENT OUTCOME IN MAJOR DEPRESSION. 89
TNF-ALPHA INHIBITION PREVENTS EARLY TIGHT JUNCTION REARRANGEMENT AND APOPTOSIS OF ILEAL ENTEROCYTES IN EXPERIMENTAL COLITIS. 88
GLYCYRRHIZIN REDUCES SECONDARY INFLAMMATORY PROCESS AFTER SPINAL CORD COMPRESSION INJURY IN MICE. 87
Inhibition of glycogen synthase kinase-3 beta attenuates the development of carrageenan-induced lung injury in mice 87
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples 86
Totale 12.540
Categoria #
all - tutte 58.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022837 4 88 24 10 22 12 48 36 13 152 154 274
2022/20232.147 168 155 93 184 191 220 10 139 890 17 54 26
2023/2024508 41 85 29 46 49 85 11 27 7 55 4 69
2024/20252.823 35 29 43 166 133 79 65 521 695 155 387 515
2025/20267.491 320 500 678 512 578 1.648 982 823 817 334 139 160
Totale 16.591